12thKumamoto AIDS Seminar Global COE Joint International Symposium | ||||
|
||||
¡3rd@October 21th, Friday @( Aso Resort GRANDVRIO Hotel 8:30-15:20 ) |
||||
* In the morning sections, venue is divided into group A and B. |
||||
Young Investigator Symposium : Group A@ 8:30-11:40 |
||||
YIS-A Session ‡T |
8:30-9:50 k80l | |||
Chair: Masateru Hiyoshi & Kazuaki Monde [Kumamoto Univ.] | ||||
20 | Peter Gee [Kyoto University, Japan] |
Biochemical characterization of the HIV-1 restriction factor SAMHD1 | ||
21 |
Katsuhiro Io [Kyoto University, Japan] |
Phosphorylation of p53 is enhanced by HIV-1 Vif and required for Vif-induced G2 cell cycle arrest and apoptosis | ||
22 |
Nobuyo Higashi-Kuwata [Kumamoto University, Japan] |
Alteration of the dynamics of HIVmc dissemination in huPBMC NOJ mice under Raltegravir administration | ||
23 |
Shigeyoshi Harada [Kumamoto University, Japan] |
Impact of raltegravir pressure on the selection of HIV-1 envelope sequences in vitro | ||
YIS-A Session ‡U@ |
10:20-11:40 k80l | |||
Chair: Masayuki Amano & Shigeyoshi Harada [Kumamoto Univ.] | ||||
24 |
Kazuhiko Maeda [Kumamoto University, Japan] |
GANP promotes APOBEC3G encapsidation in virions to reduce viral infectivity | ||
25 |
Kazuaki Monde [Kumamoto University, Japan] |
Coassembly of HERV-K Gag with HIV-1 Gag | ||
26 |
Koji Watanabe [NCGM / Kumamoto University, Japan] |
Clinical and epidemiological features of amebiasis in HIV-1-infected Japanese men | ||
27 |
Atsuko Hachiya [NCGM, Japan] |
HIV-1 Reverse Transcriptase (RT) Polymorphism 172K, Suppresses the Effect of Clinically Relevant Drug Resistance Mutations to Both Nucleoside and Nonnucleoside RT Inhibitors | ||
Young Investigator Symposium : Group B 8:30-11:40 |
||||
YIS-B Session ‡T |
8:30-9:50 k80l | |||
Chair: Philip Mwimanzi [Kumamoto Univ.] & Zabrina L. Brumme [Simon Fraser Univ., Canada] | ||||
28 |
Ken Kono [Osaka University, Japan] |
Functional and geographical diversity of antiretroviral host factor TRIMCyp in Cynomolgus macaque (Macaca fascicularis) | ||
29 |
Chihiro Motozono [Cardiff University, UK] |
The cross-reactivity footprints of HIV-specific CTLs | ||
30 |
Yusuke Takahara [NIID, Japan] |
Impact of therapeutic vaccination during HAART on CTL immunodominance in SIV infection | ||
31 |
Takayuki Chikata [Kumamoto University, Japan] |
HLA-Associated Viral Polymorphism in Chronically HIV-1-Infected Japanese Cohort | ||
YIS-B Session ‡U@ |
10:15-11:40 k85l | |||
Chair: Keiko Sakai & Madoka Koyanagi [Kumamoto Univ.] | ||||
32 |
Takeo Kuwata [Kumamoto University, Japan] |
Biased induction of neutralizing antibodies with particular specificity and gene usage in SIVsmH635FC-infected macaques | ||
33 |
Philip Mwimanzi [Kumamoto University, Japan] |
Population analysis of viral replication capacity by nef alleles of HIV elite controllers | ||
34 |
Thumbi Ndung’u [University of KwaZulu-Natal., South-Africa] |
‚hmpact of immune-driven sequence variation in hiv-1 gag-protease on viral replication capacity and disease progression | ||
35 |
Kazuo Suzuki [St Vincent's Centre for Applied Medical Research, Australia] |
Sequence specific induction of HIV-1 transcriptional gene silencing targeting NF-κB sequences by siRNA without any off-target effects of other NF-B driven genes | ||
* In the afternoon sections, groups joint venue |
||||
Session XII |
13:20-13:40 k20l | |||
Chair: Takeo Kuwata & Masao Hashimoto [Kumamoto Univ.] | ||||
36 |
Best Poster Award winner presentation Hiromi Ogata-Aoki [Kumamoto University, Japan] |
|||
Session XIII |
13:40-14:30 k50l | |||
Chair: Yasuo Ariumi [Kumamoto Univ.] | ||||
37 | Hiroyuki Gatanaga [NCGM / Kumamoto University, Japan ] |
Naturally arising V3 mutations associated with HIV-1 tropism change | ||
38 |
Zabrina L. Brumme [Simon Fraser University, Canada] |
Adaptation of HIV-1 to immune selection pressure: trends from the North American epidemic | ||
Session XIV |
14:30-15:15 k45l | |||
Chair: Seiji Okada [Kumamoto Univ.] | ||||
39 |
Shuzo Matsushita [Kumamoto University, Japan] |
Cross-subtype reactivity and neutralization activity of a panel of human monoclonal antibodies obtained from a single donor | ||
40 |
Kazuhisa Yoshimura [Kumamoto University, Japan] |
Two-step escape pathway of the HIV-1 primary isolates induced by the in vitro selection of maraviroc | ||
Home(Japanese) | ||||
Home(English) | ||||